Lamers-Kok, Nina
Panella, Denise
Georgoudaki, Anna-Maria
Liu, Haiping
Özkazanc, Didem
Kučerová, Lucia
Duru, Adil Doganay
Spanholtz, Jan
Raimo, Monica
Article History
Received: 31 August 2022
Accepted: 26 October 2022
First Online: 8 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors are employees of Glycostem Therapeutics BV, a private company developing NK cell therapies.